No Data
No Data
No Data
No Data
No Data
Ocular Therapeutix Currently Down Nine Consecutive Days, On Pace for Longest Losing Streak Since October 2019 -- Data Talk
Ocular Therapeutix Inc. (OCUL) is currently at $4.75, down $0.25 or 5% --Would be lowest close since Jan. 26, 2024, when it closed at $4.66 --Currently down 10 of the past 11 days --Currently down
Dow JonesApr 24 11:18 ET
Optimistic Buy Rating for Ocular Therapeutix Amid Early-Stage NPDR Study and Wet AMD Potential
TipRanksApr 22 01:46 ET
Baird Sees Weakness in Ocular Shares "Overdone" in Wake of Phase 1 Data
Seeking AlphaApr 19 18:07 ET
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session.The company announced its third-quarter earnings date and did not provide preliminary estimates as it did with t
BenzingaApr 19 13:25 ET
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Ocular Therapeutix (OCUL)
TipRanksApr 19 06:30 ET
Express News | HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $16 Price Target
Moomoo 24/7Apr 19 06:28 ET
No Data
No Data
Jaguar8 : Because people don’t understand how important it is.
TrytosaveabitOP Jaguar8: Right as usual! But why today the big drop? It’s almost like people misread the study! The data was great compared to the placebo/control group? Hehehe! I truly can’t figure it?
Jaguar8 TrytosaveabitOP: Maybe explain it to them brother. They probably don’t even know what placebo means
TrytosaveabitOP Jaguar8: Hehehe! You ass, I spit my coffee on my screen! OMG hehehe
Jaguar8 TrytosaveabitOP: Hahahaha
View more comments...